AlphaQuest LLC Sells 407 Shares of Teleflex Incorporated (NYSE:TFX)

AlphaQuest LLC lowered its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 19.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,739 shares of the medical technology company’s stock after selling 407 shares during the period. AlphaQuest LLC’s holdings in Teleflex were worth $310,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Janus Henderson Group PLC boosted its stake in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the period. State Street Corp boosted its position in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after purchasing an additional 21,291 shares during the period. Geode Capital Management LLC increased its holdings in shares of Teleflex by 0.5% in the third quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock valued at $278,676,000 after purchasing an additional 5,746 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Teleflex by 0.4% in the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock valued at $105,749,000 after purchasing an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. raised its position in shares of Teleflex by 31.2% in the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after purchasing an additional 96,958 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

TFX has been the topic of a number of research reports. Piper Sandler reiterated a “neutral” rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Morgan Stanley decreased their target price on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. Raymond James cut Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $220.00 to $155.00 in a report on Friday, February 28th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $182.63.

Teleflex Trading Up 1.1 %

TFX opened at $137.79 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.90. The stock has a market capitalization of $6.39 billion, a price-to-earnings ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a 50-day simple moving average of $166.99 and a 200 day simple moving average of $197.99.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.99%. Teleflex’s dividend payout ratio (DPR) is currently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.